4582.T
SymBio Pharmaceuticals Limited
グロース · 医薬品 · 医薬品 · JP
JPY 61.00
−1.61%Margins
Gross margin
74.2%
EBITDA margin
—
EBIT margin
-439.8%
Net margin
-458.9%
FCF margin
—
-2535.1%
Return on equity
-198.8%
Return on assets
-1224.0%
Return on invested capital
0.37x
Asset turnover
-JPY 4.6B
Cash from operations
JPY 26
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026